MTVA

Latest SEC Filings & News for MTVA

2 most recent filings and news items mentioning MTVA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/MTVA/news?limit=20"

Pull MTVA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
OtherJun 8, 2026Positive

MetaVia presents obesity drug data showing 9.1% weight loss at ADA 2026

MetaVia announced Phase 1 results for DA-1726 showing up to 9.1% mean body weight reduction and preclinical data supporting combination therapies for metabolic diseases. The data demonstrates potential differentiation of the company's cardiometabolic pipeline and supports advance

View filing at SEC.gov →
RegulatoryMay 27, 2026Positive

MetaVia's DA-1726 achieves 9.1% weight loss in Phase 1 obesity trial

MetaVia presented Phase 1 results for DA-1726 showing up to 9.1% mean body weight reduction at 48 mg dose with favorable safety and early liver improvements at EASL 2026. The dual GLP-1/glucagon receptor agonist demonstrates potential for obesity and MASH treatment with ongoing P

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.